Duke University Health System - Duke Clinic — Durham, North Carolina

Duke University Health System - Duke Clinic is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Clinical Trials Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Duke University Health System - Duke Clinic has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases.

Sponsors: Pulmovant, Inc., Bristol-Myers Squibb, Eidos Therapeutics, a BridgeBio company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Durham

Browse all research sites in North Carolina · View every site in Durham

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Health System - Duke Clinic?

Duke University Health System - Duke Clinic has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Health System - Duke Clinic conducted?

Duke University Health System - Duke Clinic has 3 clinical trials on record, with 2 currently active. Their work covers Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases.

Is Duke University Health System - Duke Clinic accredited by Crixeo Clinical Trials?

Duke University Health System - Duke Clinic has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University Health System - Duke Clinic?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.